Dysregulated metabolism contributes to oncogenesisMatthew D. Hirschey, Kathryn E. Wellen, Ralph J. DeBerardinis et al.|Seminars in Cancer Biology|2015Cited by 318
Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-NorleucineSabrina Wang, Jeffrey Rubens, Brad Poore et al.|Clinical Cancer Research|2019Cited by 34
Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatinBrad Poore, Eric H. Raabe, Antoinette Price et al.|Neuro-Oncology|2018Cited by 28
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine PathwaysKhoa Pham, Eric H. Raabe, Allison R. Hanaford et al.|Cancers|2022Cited by 21
TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastomaRachael Maynard, Eric H. Raabe, Brad Poore et al.|Cancer Letters|2021Cited by 9